PREMARIN VAGINAL CREAM

Share :

Related Products

  • Brand Name: Premarin Vaginal Cream

  • Generic Name: Conjugated Estrogens (USP)

  • Therapeutic Class: Topical Estrogen Therapy

  • Formulation: 0.625 mg conjugated estrogens per gram of cream

  • Delivery System: Graduated applicator for precise dosing


2. COMPOSITION

Component Concentration Purpose
Conjugated Estrogens (USP) 0.625 mg/g Active ingredient
Cetyl Esters Wax 7% Emollient base
Glycerin 5% Humectant
Propylene Glycol 3% Solvent/Preservative
Methylparaben 0.18% Preservative

3. MECHANISM OF ACTION

  • Local estrogenic effects on vaginal epithelium:

    • Restores vaginal pH (↓ from ~6.0 to ~4.5)

    • Increases blood flow to urogenital tissues

    • Thickens vaginal epithelium (maturation index improvement)

    • Enhances cervical mucus production

  • Minimal systemic absorption:

    • Serum estradiol levels typically remain in postmenopausal range

    • First-pass hepatic metabolism avoided


4. DOSAGE & ADMINISTRATION

Standard Dosing Schedule

Phase Dose (g) Estrogen Content Frequency Duration
Initial 0.5-2 g 0.31-1.25 mg Daily 2-4 weeks
Maintenance 0.5-1 g 0.31-0.625 mg 2-3× weekly Ongoing

Administration Guide

  1. Wash hands before application

  2. Fill applicator to prescribed dose marking

  3. Insert deeply into vagina (best at bedtime)

  4. Avoid intercourse for 1 hour post-application


5. INDICATIONS

✅ Moderate-to-severe dyspareunia due to menopause ✅ Vaginal dryness/itching/burning (vulvovaginal atrophy) ✅ Urinary symptoms (dysuria, urgency) from urogenital atrophy ✅ Pre-procedure preparation for postmenopausal pelvic surgery


6. STORAGE CONDITIONS

  • Temperature: 20-25°C (68-77°F)

  • Post-Opening: Use within 3 months

  • Protection: Keep tube tightly closed

  • Do not freeze


7. KEY RECOMMENDATIONS

✔ Start with lowest effective dose (0.5 g daily) ✔ Re-evaluate need every 3-6 months (consider non-hormonal alternatives) ✔ Use vaginal moisturizers concomitantly for optimal symptom relief ✔ Monitor endometrial thickness if used >1 year (transvaginal ultrasound)


8. IMPORTANT SAFETY INFORMATION

Black Box Warnings

⚠ Endometrial Cancer Risk:

  • Unopposed estrogen increases risk (add progestogen if uterus present)

  • Monitor for abnormal bleeding

⚠ Cardiovascular/Thromboembolic Risks:

  • Lower than oral estrogens but still present

Contraindications

❌ Undiagnosed vaginal bleeding ❌ Estrogen-dependent neoplasia ❌ Active arterial thromboembolism ❌ Pregnancy (Category X)

Adverse Effects

Common (≥5%) Serious (<1%)
Vaginal spotting Endometrial hyperplasia
Breast tenderness Venous thromboembolism
Headache Gallbladder disease

9. COMPARISON WITH OTHER VAGINAL ESTROGENS

Parameter Premarin Cream Estradiol Tablet Vaginal Ring
Estrogen Type Conjugated 17β-estradiol Estradiol acetate
Dosing Frequency 2-3× weekly Daily Every 3 months
Systemic Absorption Low Very low Low
Cost/Month $$ $ $$$

10. PATIENT COUNSELING POINTS

✔ Proper applicator cleaning (wash with mild soap after use) ✔ Expected timeline for improvement (full effects in 1-3 months) ✔ Warning signs to report:

  • New breast lumps

  • Severe headaches

  • Visual changes

  • Leg pain/swelling

✔ Alternate options:

  • Non-hormonal moisturizers (e.g., Replens)

  • Regular sexual activity to maintain blood flow


CONCLUSION

Premarin Vaginal Cream provides effective localized estrogen therapy for urogenital atrophy with minimal systemic effects. While safer than oral estrogens, it still requires regular monitoring and should be used at the lowest effective dose for the shortest duration.

  • Brand Name: Premarin Vaginal Cream

  • Generic Name: Conjugated Estrogens (USP)

  • Therapeutic Class: Topical Estrogen Therapy

  • Formulation: 0.625 mg conjugated estrogens per gram of cream

  • Delivery System: Graduated applicator for precise dosing


2. COMPOSITION

Component Concentration Purpose
Conjugated Estrogens (USP) 0.625 mg/g Active ingredient
Cetyl Esters Wax 7% Emollient base
Glycerin 5% Humectant
Propylene Glycol 3% Solvent/Preservative
Methylparaben 0.18% Preservative

3. MECHANISM OF ACTION

  • Local estrogenic effects on vaginal epithelium:

    • Restores vaginal pH (↓ from ~6.0 to ~4.5)

    • Increases blood flow to urogenital tissues

    • Thickens vaginal epithelium (maturation index improvement)

    • Enhances cervical mucus production

  • Minimal systemic absorption:

    • Serum estradiol levels typically remain in postmenopausal range

    • First-pass hepatic metabolism avoided


4. DOSAGE & ADMINISTRATION

Standard Dosing Schedule

Phase Dose (g) Estrogen Content Frequency Duration
Initial 0.5-2 g 0.31-1.25 mg Daily 2-4 weeks
Maintenance 0.5-1 g 0.31-0.625 mg 2-3× weekly Ongoing

Administration Guide

  1. Wash hands before application

  2. Fill applicator to prescribed dose marking

  3. Insert deeply into vagina (best at bedtime)

  4. Avoid intercourse for 1 hour post-application


5. INDICATIONS

✅ Moderate-to-severe dyspareunia due to menopause
✅ Vaginal dryness/itching/burning (vulvovaginal atrophy)
✅ Urinary symptoms (dysuria, urgency) from urogenital atrophy
✅ Pre-procedure preparation for postmenopausal pelvic surgery


6. STORAGE CONDITIONS

  • Temperature: 20-25°C (68-77°F)

  • Post-Opening: Use within 3 months

  • Protection: Keep tube tightly closed

  • Do not freeze


7. KEY RECOMMENDATIONS

✔ Start with lowest effective dose (0.5 g daily)
✔ Re-evaluate need every 3-6 months (consider non-hormonal alternatives)
✔ Use vaginal moisturizers concomitantly for optimal symptom relief
✔ Monitor endometrial thickness if used >1 year (transvaginal ultrasound)


8. IMPORTANT SAFETY INFORMATION

Black Box Warnings

⚠ Endometrial Cancer Risk:

  • Unopposed estrogen increases risk (add progestogen if uterus present)

  • Monitor for abnormal bleeding

⚠ Cardiovascular/Thromboembolic Risks:

  • Lower than oral estrogens but still present

Contraindications

❌ Undiagnosed vaginal bleeding
❌ Estrogen-dependent neoplasia
❌ Active arterial thromboembolism
❌ Pregnancy (Category X)

Adverse Effects

Common (≥5%) Serious (<1%)
Vaginal spotting Endometrial hyperplasia
Breast tenderness Venous thromboembolism
Headache Gallbladder disease

9. COMPARISON WITH OTHER VAGINAL ESTROGENS

Parameter Premarin Cream Estradiol Tablet Vaginal Ring
Estrogen Type Conjugated 17β-estradiol Estradiol acetate
Dosing Frequency 2-3× weekly Daily Every 3 months
Systemic Absorption Low Very low Low
Cost/Month $$ $ $$$

10. PATIENT COUNSELING POINTS

✔ Proper applicator cleaning (wash with mild soap after use)
✔ Expected timeline for improvement (full effects in 1-3 months)
✔ Warning signs to report:

  • New breast lumps

  • Severe headaches

  • Visual changes

  • Leg pain/swelling

✔ Alternate options:

  • Non-hormonal moisturizers (e.g., Replens)

  • Regular sexual activity to maintain blood flow


CONCLUSION

Premarin Vaginal Cream provides effective localized estrogen therapy for urogenital atrophy with minimal systemic effects. While safer than oral estrogens, it still requires regular monitoring and should be used at the lowest effective dose for the shortest duration.

We offer a variety of shipping options, including Express Mail Service (EMS), USPS, DHL, FedEx, TNT, UPS, Aramex, Air Cargo, and sea freight.

Terms and Conditions – 

Bulk Orders: You are responsible for any local import duties and taxes in your country.

For Patients: When ordering prescription medicines for personal use, or for a friend or relative, a valid medical practitioner’s script or prescription is required.

Return and Refund Policy: Due to the nature of our products, we cannot accept returns or exchanges once a purchase is made. However, in the event of non-delivery, you are eligible for either a 100% refund or a reshipment of your order.

  • Brand Name: Premarin Vaginal Cream

  • Generic Name: Conjugated Estrogens (USP)

  • Therapeutic Class: Topical Estrogen Therapy

  • Formulation: 0.625 mg conjugated estrogens per gram of cream

  • Delivery System: Graduated applicator for precise dosing


2. COMPOSITION

Component Concentration Purpose
Conjugated Estrogens (USP) 0.625 mg/g Active ingredient
Cetyl Esters Wax 7% Emollient base
Glycerin 5% Humectant
Propylene Glycol 3% Solvent/Preservative
Methylparaben 0.18% Preservative

3. MECHANISM OF ACTION

  • Local estrogenic effects on vaginal epithelium:

    • Restores vaginal pH (↓ from ~6.0 to ~4.5)

    • Increases blood flow to urogenital tissues

    • Thickens vaginal epithelium (maturation index improvement)

    • Enhances cervical mucus production

  • Minimal systemic absorption:

    • Serum estradiol levels typically remain in postmenopausal range

    • First-pass hepatic metabolism avoided


4. DOSAGE & ADMINISTRATION

Standard Dosing Schedule

Phase Dose (g) Estrogen Content Frequency Duration
Initial 0.5-2 g 0.31-1.25 mg Daily 2-4 weeks
Maintenance 0.5-1 g 0.31-0.625 mg 2-3× weekly Ongoing

Administration Guide

  1. Wash hands before application

  2. Fill applicator to prescribed dose marking

  3. Insert deeply into vagina (best at bedtime)

  4. Avoid intercourse for 1 hour post-application


5. INDICATIONS

✅ Moderate-to-severe dyspareunia due to menopause
✅ Vaginal dryness/itching/burning (vulvovaginal atrophy)
✅ Urinary symptoms (dysuria, urgency) from urogenital atrophy
✅ Pre-procedure preparation for postmenopausal pelvic surgery


6. STORAGE CONDITIONS

  • Temperature: 20-25°C (68-77°F)

  • Post-Opening: Use within 3 months

  • Protection: Keep tube tightly closed

  • Do not freeze


7. KEY RECOMMENDATIONS

✔ Start with lowest effective dose (0.5 g daily)
✔ Re-evaluate need every 3-6 months (consider non-hormonal alternatives)
✔ Use vaginal moisturizers concomitantly for optimal symptom relief
✔ Monitor endometrial thickness if used >1 year (transvaginal ultrasound)


8. IMPORTANT SAFETY INFORMATION

Black Box Warnings

⚠ Endometrial Cancer Risk:

  • Unopposed estrogen increases risk (add progestogen if uterus present)

  • Monitor for abnormal bleeding

⚠ Cardiovascular/Thromboembolic Risks:

  • Lower than oral estrogens but still present

Contraindications

❌ Undiagnosed vaginal bleeding
❌ Estrogen-dependent neoplasia
❌ Active arterial thromboembolism
❌ Pregnancy (Category X)

Adverse Effects

Common (≥5%) Serious (<1%)
Vaginal spotting Endometrial hyperplasia
Breast tenderness Venous thromboembolism
Headache Gallbladder disease

9. COMPARISON WITH OTHER VAGINAL ESTROGENS

Parameter Premarin Cream Estradiol Tablet Vaginal Ring
Estrogen Type Conjugated 17β-estradiol Estradiol acetate
Dosing Frequency 2-3× weekly Daily Every 3 months
Systemic Absorption Low Very low Low
Cost/Month $$ $ $$$

10. PATIENT COUNSELING POINTS

✔ Proper applicator cleaning (wash with mild soap after use)
✔ Expected timeline for improvement (full effects in 1-3 months)
✔ Warning signs to report:

  • New breast lumps

  • Severe headaches

  • Visual changes

  • Leg pain/swelling

✔ Alternate options:

  • Non-hormonal moisturizers (e.g., Replens)

  • Regular sexual activity to maintain blood flow


CONCLUSION

Premarin Vaginal Cream provides effective localized estrogen therapy for urogenital atrophy with minimal systemic effects. While safer than oral estrogens, it still requires regular monitoring and should be used at the lowest effective dose for the shortest duration.

Reviews

There are no reviews yet.

Be the first to review “PREMARIN VAGINAL CREAM”

Your email address will not be published. Required fields are marked *

  • Brand Name: Premarin Vaginal Cream

  • Generic Name: Conjugated Estrogens (USP)

  • Therapeutic Class: Topical Estrogen Therapy

  • Formulation: 0.625 mg conjugated estrogens per gram of cream

  • Delivery System: Graduated applicator for precise dosing


2. COMPOSITION

Component Concentration Purpose
Conjugated Estrogens (USP) 0.625 mg/g Active ingredient
Cetyl Esters Wax 7% Emollient base
Glycerin 5% Humectant
Propylene Glycol 3% Solvent/Preservative
Methylparaben 0.18% Preservative

3. MECHANISM OF ACTION

  • Local estrogenic effects on vaginal epithelium:

    • Restores vaginal pH (↓ from ~6.0 to ~4.5)

    • Increases blood flow to urogenital tissues

    • Thickens vaginal epithelium (maturation index improvement)

    • Enhances cervical mucus production

  • Minimal systemic absorption:

    • Serum estradiol levels typically remain in postmenopausal range

    • First-pass hepatic metabolism avoided


4. DOSAGE & ADMINISTRATION

Standard Dosing Schedule

Phase Dose (g) Estrogen Content Frequency Duration
Initial 0.5-2 g 0.31-1.25 mg Daily 2-4 weeks
Maintenance 0.5-1 g 0.31-0.625 mg 2-3× weekly Ongoing

Administration Guide

  1. Wash hands before application

  2. Fill applicator to prescribed dose marking

  3. Insert deeply into vagina (best at bedtime)

  4. Avoid intercourse for 1 hour post-application


5. INDICATIONS

✅ Moderate-to-severe dyspareunia due to menopause
✅ Vaginal dryness/itching/burning (vulvovaginal atrophy)
✅ Urinary symptoms (dysuria, urgency) from urogenital atrophy
✅ Pre-procedure preparation for postmenopausal pelvic surgery


6. STORAGE CONDITIONS

  • Temperature: 20-25°C (68-77°F)

  • Post-Opening: Use within 3 months

  • Protection: Keep tube tightly closed

  • Do not freeze


7. KEY RECOMMENDATIONS

✔ Start with lowest effective dose (0.5 g daily)
✔ Re-evaluate need every 3-6 months (consider non-hormonal alternatives)
✔ Use vaginal moisturizers concomitantly for optimal symptom relief
✔ Monitor endometrial thickness if used >1 year (transvaginal ultrasound)


8. IMPORTANT SAFETY INFORMATION

Black Box Warnings

⚠ Endometrial Cancer Risk:

  • Unopposed estrogen increases risk (add progestogen if uterus present)

  • Monitor for abnormal bleeding

⚠ Cardiovascular/Thromboembolic Risks:

  • Lower than oral estrogens but still present

Contraindications

❌ Undiagnosed vaginal bleeding
❌ Estrogen-dependent neoplasia
❌ Active arterial thromboembolism
❌ Pregnancy (Category X)

Adverse Effects

Common (≥5%) Serious (<1%)
Vaginal spotting Endometrial hyperplasia
Breast tenderness Venous thromboembolism
Headache Gallbladder disease

9. COMPARISON WITH OTHER VAGINAL ESTROGENS

Parameter Premarin Cream Estradiol Tablet Vaginal Ring
Estrogen Type Conjugated 17β-estradiol Estradiol acetate
Dosing Frequency 2-3× weekly Daily Every 3 months
Systemic Absorption Low Very low Low
Cost/Month $$ $ $$$

10. PATIENT COUNSELING POINTS

✔ Proper applicator cleaning (wash with mild soap after use)
✔ Expected timeline for improvement (full effects in 1-3 months)
✔ Warning signs to report:

  • New breast lumps

  • Severe headaches

  • Visual changes

  • Leg pain/swelling

✔ Alternate options:

  • Non-hormonal moisturizers (e.g., Replens)

  • Regular sexual activity to maintain blood flow


CONCLUSION

Premarin Vaginal Cream provides effective localized estrogen therapy for urogenital atrophy with minimal systemic effects. While safer than oral estrogens, it still requires regular monitoring and should be used at the lowest effective dose for the shortest duration.

Reviews

There are no reviews yet.

Be the first to review “PREMARIN VAGINAL CREAM”

Your email address will not be published. Required fields are marked *

Medical Disclaimer

Anteka Pharmacy primary intention is to ensure that its consumers get information that is reviewed by experts, accurate and trustworthy. The information and contents of this website are for informational purposes only. They are not intended to be a substitute for professional medical advice, diagnosis, or treatment. Please seek the advice of your doctor and discuss all your queries related to any disease or medicine. Do not disregard professional medical advice or delay in seeking it because of something you have read on Anteka Pharmacy. Our mission is to support, not replace, the doctor-patient relationship.
Scroll to Top

Log in

Create an Account

Send Enquiry For PREMARIN VAGINAL CREAM